Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
(Image credit: Svitlana Pietukhova/iStockphoto)
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.(Image credit: Svitlana Pietukhova/iStockphoto)
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
(Image credit: Svitlana Pietukhova/iStockphoto)